Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiglidine vs sufentanil for perioperative analgesia in ambulatory hysteroscopic surgery
ChiCTR2600122358Phase 4Recruiting
- Sponsor
- Guangzhou Women and Children’s Medical Center
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine (3 arms), sponsored by Guangzhou Women and Children’s Medical Center. Primary endpoint: Incidence of postoperative nausea and vomiting (PONV). Started Apr 2026; status: recruiting.
02
Drugs
tegileridine
Beyond the preview
Go deeper on ChiCTR2600122358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122358.